Enhanced surveillance of primary measles mumps and rubella (MMR) immunisation in Wales

Author： Mason B.W. Thomas D.R. Salmon R.L.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.31, 2002-11, pp. : 3635-3637

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance

By Pebody R.G. Gay N.J. Hesketh L.M. Vyse A. Morgan-Capner P. Brown D.W. Litton P. Miller E.

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1134-1140

Elsevier

Access to resources Recommend Favorite

Familial adverse events after measles-mumps-rubella (MMR) vaccination

By Guala A. Garipoli V. Pastore G. Pagani L.

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 991-991

Elsevier

Access to resources Recommend Favorite

Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland

By Davidkin

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3106-3112

Elsevier

Access to resources Recommend Favorite

Study of the immune response engendered by differents combined measles, mumps and rubella (MMR) vaccines in an area of Andalusia (Spain)

By Rojo C.C. Iglesias M.R. Olvera J. Giron M.A.

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 280-286

Elsevier

Access to resources Recommend Favorite

Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age *

By Klinge

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3134-3140

Elsevier

Access to resources Recommend Favorite